Literature DB >> 15932465

Australia-wide comparison of intensity modulated radiation therapy prostate plans.

M Skala1, L Holloway, M Bailey, A Kneebone.   

Abstract

The aim of this study was to investigate the ability of Australian centres to produce high-dose intensity modulated radiation therapy (IMRT) prostate plans, and to compare the planning parameters and resultant dose distributions. Five Australian radiation therapy departments were invited to participate. Each centre received an identical 5 mm-slice CT data set complete with contours of the prostate, seminal vesicles, rectum, bladder, femoral heads and body outline. The planning team was asked to produce the best plan possible, using published Memorial Sloan-Kettering Cancer Centre prescription and dose constraints. Three centres submitted plans for evaluation. All plans covered the planning target volume adequately; however, only one plan met all the critical organ dose constraints. Although the planning parameters, beam arrangements and planning systems were different for each centre, the resulting plans were similar. In Australia, IMRT for prostate cancer is in the early stages of implementation, with routine use limited to a few centres.

Entities:  

Mesh:

Year:  2005        PMID: 15932465     DOI: 10.1111/j.1440-1673.2005.01419.x

Source DB:  PubMed          Journal:  Australas Radiol        ISSN: 0004-8461


  4 in total

1.  Dosimetric comparison between volumetric modulated arc therapy planning techniques for prostate cancer in the presence of intrafractional organ deformation.

Authors:  Maria Varnava; Iori Sumida; Michio Oda; Keita Kurosu; Fumiaki Isohashi; Yuji Seo; Keisuke Otani; Kazuhiko Ogawa
Journal:  J Radiat Res       Date:  2021-03-10       Impact factor: 2.724

2.  Detailed dosimetric evaluation of intensity-modulated radiation therapy plans created for stage C prostate cancer based on a planning protocol.

Authors:  Yoshiki Norihisa; Takashi Mizowaki; Kenji Takayama; Yuki Miyabe; Kiyotomo Matsugi; Yukinori Matsuo; Masaru Narabayashi; Katsuyuki Sakanaka; Akira Nakamura; Yasushi Nagata; Masahiro Hiraoka
Journal:  Int J Clin Oncol       Date:  2011-09-29       Impact factor: 3.402

3.  Quality assurance for the EORTC 22071-26071 study: dummy run prospective analysis.

Authors:  Alysa Fairchild; Johannes A Langendijk; Sandra Nuyts; Christopher Scrase; Milan Tomsej; Danny Schuring; Akos Gulyban; Sunita Ghosh; Damien C Weber; Wilfried Budach
Journal:  Radiat Oncol       Date:  2014-11-26       Impact factor: 3.481

4.  Surveillance on interfacility differences in dose-prescription policy of intensity-modulated radiation therapy plans for prostate cancer.

Authors:  Takashi Mizowaki; Kazuo Hatano; Masahiro Hiraoka
Journal:  J Radiat Res       Date:  2012-06-06       Impact factor: 2.724

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.